Inspection and Testing Compliance in Quality Assurance

Inspection and testing compliance defines the systematic obligations organizations must meet when evaluating products, materials, processes, and systems against specified requirements before, during, and after production. Governed by frameworks ranging from ISO 9001 to FDA regulations, these obligations span virtually every regulated industry in the United States. Noncompliance in this domain produces measurable consequences: product recalls, regulatory enforcement actions, and failed third-party audits that halt manufacturing or distribution. This page covers the definition and scope of inspection and testing compliance, the mechanisms by which it operates, the scenarios in which it applies, and the boundaries that separate compliant from noncompliant practice.

Definition and scope

Inspection and testing compliance refers to the structured set of requirements that govern how an organization verifies product or process conformity at defined control points. It encompasses incoming inspection of raw materials, in-process inspection during fabrication or assembly, and final inspection and testing before release to customers or the market.

The scope is established by two intersecting sources of authority: contractual or customer requirements, and regulatory mandates from bodies such as the U.S. Food and Drug Administration (FDA), the Occupational Safety and Health Administration (OSHA), and the Federal Aviation Administration (FAA). Standards bodies including ISO (International Organization for Standardization) and ASTM International publish technical criteria that define acceptable test methods and acceptance thresholds.

Under ISO 9001:2015, clause 8.6 specifically requires that organizations not release products and services until all planned arrangements for verifying conformity have been completed, unless approved by a relevant authority or customer. The FDA's Quality System Regulation under 21 CFR Part 820 (now being transitioned to the Quality Management System Regulation, 21 CFR Part 820 as aligned with ISO 13485) similarly mandates documented inspection procedures for medical device manufacturers. Full alignment with FDA quality system regulation requirements means maintaining device history records that capture every acceptance activity.

How it works

Inspection and testing compliance operates through a lifecycle of verification stages, each governed by documented procedures and controlled records.

1. Planning — Inspection and test plans (ITPs) are developed during product or process design, identifying what is to be inspected, by whom, using which measurement tools, and to what acceptance criteria. This planning step links directly to risk-based compliance in QA, because higher-risk characteristics typically require more rigorous inspection frequencies or destructive testing.

2. Incoming inspection — Materials, components, and subassemblies are evaluated against purchase specifications before entering production. The depth of incoming inspection may be reduced through supplier qualification programs, but the decision to reduce must be documented and justified.

3. In-process inspection — Checkpoints are embedded within the manufacturing or service delivery sequence. Statistical process control (SPC) techniques, including control charts governed by methods defined in ASTM E2587, may be used to monitor process stability in real time.

4. Final inspection and testing — Finished products are tested against acceptance criteria defined in product specifications or regulatory submissions. Medical devices, for example, must pass final acceptance activities as required by 21 CFR Part 820.80.

5. Record retention — All inspection and test results must be documented and retained for periods defined by regulation or contract. ISO 9001:2015 requires organizations to retain documented information as evidence of conformity (clause 8.6). Quality assurance recordkeeping compliance governs the specific controls for these records.

6. Nonconformance disposition — Items failing inspection are segregated and dispositioned through a formal corrective process linked to nonconformance compliance management.

Common scenarios

Manufacturing and medical devices — FDA-regulated device manufacturers must maintain device history records showing that each unit passed defined acceptance tests. A failure to document final inspection results is classified as a 21 CFR Part 820 violation and is among the top 5 FDA Form 483 observations cited annually (FDA Inspections, Compliance, Enforcement, and Criminal Investigations database).

Aerospace — Under AS9100 Rev D, clause 8.6 requires that all products conform to requirements before delivery. First Article Inspection (FAI) is a formal process in AS9100-governed supply chains, where the first production unit is comprehensively inspected against the engineering drawing. See AS9100 compliance for aerospace-specific obligations.

Automotive — The IATF 16949:2016 standard, developed by the International Automotive Task Force, requires incoming product conformance verification and control plans that specify inspection methods for each manufacturing step. IATF 16949 compliance frameworks include measurement system analysis (MSA) to validate that gauges and instruments are capable of the precision required.

Construction and civil works — ASTM International standards and local building codes require third-party special inspections for structural steel, concrete, and fire protection systems. The International Building Code (IBC), administered at the state level, mandates independent inspection agencies in defined construction categories.

Decision boundaries

Distinguishing compliant from noncompliant inspection practice turns on four boundaries:

Documented vs. undocumented activity — Inspection performed without a written record does not satisfy quality system requirements, regardless of whether the product conforms. Under ISO 9001 and FDA QSR, the record is the compliance artifact.

Calibrated vs. uncalibrated equipment — Using measurement devices that fall outside calibration intervals invalidates test results for compliance purposes. ISO 10012 and NIST Handbook 44 establish metrological traceability requirements that differentiate valid from invalid measurement.

Qualified vs. unqualified inspectors — Personnel performing specialized inspection activities (e.g., weld inspection to AWS D1.1, nondestructive testing per ASNT SNT-TC-1A) must hold documented qualifications. An inspection performed by unqualified personnel is a documented nonconformance under most regulatory frameworks.

Representative vs. non-representative sampling — Sampling plans must be statistically valid. ANSI/ASQ Z1.4 (attribute sampling) and ANSI/ASQ Z1.9 (variable sampling) provide standardized acceptance sampling tables. Arbitrary sample selection without a defined sampling plan does not satisfy compliance requirements, even if the sample passes testing.

References

• ISO 9001:2015 — Quality Management Systems Requirements (ISO)
• 21 CFR Part 820 — Quality System Regulation (FDA / eCFR)
• FDA Inspections, Compliance, Enforcement, and Criminal Investigations
• ASTM E2587 — Standard Practice for Use of Control Charts in Statistical Process Control (ASTM International)
• ANSI/ASQ Z1.4 — Sampling Procedures and Tables for Inspection by Attributes (ASQ)
• ANSI/ASQ Z1.9 — Sampling Procedures and Tables for Inspection by Variables (ASQ)
• NIST Handbook 44 — Specifications, Tolerances, and Other Technical Requirements (NIST)
• AS9100 Rev D — Quality Management Systems Requirements for Aviation, Space, and Defense (SAE International)
• IATF 16949:2016 — Quality Management System Requirements for Automotive Production (IATF)